Cargando…

Cardiac Abnormalities in a Predictive Mouse Model of Chagas Disease

Chronic Chagas cardiomyopathy (CCC) results from infection with the protozoan parasite Trypanosoma cruzi and is a prevalent cause of heart disease in endemic countries. We previously found that cardiac fibrosis can vary widely in C3H/HeN mice chronically infected with T. cruzi JR strain, mirroring t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Francisco, Amanda Fortes, Sousa, Giovane R., Vaughan, Mhairi, Langston, Harry, Khan, Archie, Jayawardhana, Shiromani, Taylor, Martin C., Lewis, Michael D., Kelly, John M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10674564/ https://www.ncbi.nlm.nih.gov/pubmed/38003828 http://dx.doi.org/10.3390/pathogens12111364

Ejemplares similares

Imaging the development of chronic Chagas disease after oral transmission
por: Lewis, Michael D., et al.
Publicado: (2018)

Assessing the Effectiveness of Curative Benznidazole Treatment in Preventing Chronic Cardiac Pathology in Experimental Models of Chagas Disease
por: Francisco, Amanda Fortes, et al.
Publicado: (2018)

Biological factors that impinge on Chagas disease drug development
por: FRANCISCO, AMANDA F., et al.
Publicado: (2017)

Challenges in Chagas Disease Drug Development
por: Francisco, Amanda F., et al.
Publicado: (2020)

Host and parasite genetics shape a link between Trypanosoma cruzi infection dynamics and chronic cardiomyopathy
por: Lewis, Michael D., et al.
Publicado: (2016)

Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure
por: Francisco, Amanda Fortes, et al.
Publicado: (2022)

Limited Ability of Posaconazole To Cure both Acute and Chronic Trypanosoma cruzi Infections Revealed by Highly Sensitive In Vivo Imaging
por: Francisco, Amanda Fortes, et al.
Publicado: (2015)

In Vivo Analysis of Trypanosoma cruzi Persistence Foci at Single-Cell Resolution
por: Ward, Alexander I., et al.
Publicado: (2020)

Intracellular DNA replication and differentiation of Trypanosoma cruzi is asynchronous within individual host cells in vivo at all stages of infection
por: Taylor, Martin C., et al.
Publicado: (2020)

Benznidazole treatment leads to DNA damage in Trypanosoma cruzi and the persistence of rare widely dispersed non-replicative amastigotes in mice
por: Jayawardhana, Shiromani, et al.
Publicado: (2023)

Expanding the toolbox for Trypanosoma cruzi: A parasite line incorporating a bioluminescence-fluorescence dual reporter and streamlined CRISPR/Cas9 functionality for rapid in vivo localisation and phenotyping
por: Costa, Fernanda Cristina, et al.
Publicado: (2018)

Nitroheterocyclic drugs cure experimental Trypanosoma cruzi infections more effectively in the chronic stage than in the acute stage
por: Francisco, Amanda Fortes, et al.
Publicado: (2016)

Plasma Cytokine Expression Is Associated with Cardiac Morbidity in Chagas Disease
por: Sousa, Giovane Rodrigo, et al.
Publicado: (2014)

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection
por: Mann, Gurdip Singh, et al.
Publicado: (2020)

Aptamer-Based Detection of Disease Biomarkers in Mouse Models for Chagas Drug Discovery
por: de Araujo, Fernanda Fortes, et al.
Publicado: (2015)

Local association of Trypanosoma cruzi chronic infection foci and enteric neuropathic lesions at the tissue micro-domain scale
por: Khan, Archie A., et al.
Publicado: (2021)

New Imaging Parameters to Predict Sudden Cardiac Death in Chagas Disease
por: Moll-Bernardes, Renata J., et al.
Publicado: (2020)

MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease
por: Medeiros, Nayara I., et al.
Publicado: (2019)

Cardiac Magnetic Resonance Imaging Detects Myocardial Abnormalities in Naturally Infected Dogs with Chronic Asymptomatic Chagas Disease
por: Matthews, Derek J., et al.
Publicado: (2023)

Monitoring the parasite load in chronic Chagas disease patients: comparison between blood culture and quantitative real time PCR
por: D’Ávila, Daniella Alchaar, et al.
Publicado: (2018)

Heart Rate Recovery in Asymptomatic Patients with Chagas Disease
por: de Alencar, Maria Clara Noman, et al.
Publicado: (2014)

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

Cardiac Autonomic Control Mechanisms in the Pathogenesis of Chagas' Heart Disease
por: Dávila, Diego F., et al.
Publicado: (2012)

Progression of Baseline Electrocardiogram Abnormalities in Chagas Patients Undergoing Antitrypanosomal Treatment
por: Soverow, Jonathan, et al.
Publicado: (2019)

Chagas Disease-induced Sudden Cardiac Arrest
por: Neeki, Michael M., et al.
Publicado: (2017)

Cardiac inflammation and ventricular tachycardia in Chagas disease
por: Shapiro, Hilary, et al.
Publicado: (2017)

A New Experimental Model for Assessing Drug Efficacy against Trypanosoma cruzi Infection Based on Highly Sensitive In Vivo Imaging
por: Lewis, Michael D., et al.
Publicado: (2015)

Increase of reactive oxygen species by desferrioxamine during experimental Chagas' disease
por: Francisco, Amanda Fortes, et al.
Publicado: (2013)

Vaccine-linked chemotherapy improves cardiac structure and function in a mouse model of chronic Chagas disease
por: Jones, Kathryn M., et al.
Publicado: (2023)

Cognitive dysfunction in chronic Chagas disease cardiomyopathy
por: Dias, Jesângeli Sousa, et al.
Publicado: (2009)

The Thymus in Chagas Disease: Molecular Interactions Involved in Abnormal T-Cell Migration and Differentiation
por: Pérez, Ana Rosa, et al.
Publicado: (2020)

Different Infective Forms Trigger Distinct Immune Response in Experimental Chagas Disease
por: Vieira, Paula Melo de Abreu, et al.
Publicado: (2012)

Immunopathological Mechanisms Underlying Cardiac Damage in Chagas Disease
por: De Alba-Alvarado, Mariana Citlalli, et al.
Publicado: (2023)

Electrocardiographic abnormalities in Chagas disease in the general population: A systematic review and meta-analysis
por: Rojas, Lyda Z., et al.
Publicado: (2018)

Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease
por: Medeiros, Nayara I., et al.
Publicado: (2017)

Fatal progression of experimental visceral leishmaniasis is associated with intestinal parasitism and secondary infection by commensal bacteria, and is delayed by antibiotic prophylaxis
por: Lewis, Michael D., et al.
Publicado: (2020)

Detection of myocardial inflammation in Chagas' disease by cardiac magnetic resonance
por: Torreão, Jorge A, et al.
Publicado: (2013)

The role of interleukin 17-mediated immune response in Chagas disease: High level is correlated with better left ventricular function
por: Sousa, Giovane R., et al.
Publicado: (2017)

The Trypanosoma cruzi Vitamin C Dependent Peroxidase Confers Protection against Oxidative Stress but Is Not a Determinant of Virulence
por: Taylor, Martin C., et al.
Publicado: (2015)

Physician Awareness of Chagas Disease, USA
por: Stimpert, Kelly K., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_jcinh9mu5cjghtff7mbapon2c7